Where I see patients (1)
My reviews
Selected research
-
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Nature medicine
-
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker.
Clinical epigenetics
-
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
Neuro-oncology
Contact me
- Request appointment
- Refer a patient
- (415) 353-2966
4.9